Glycopyrronium Tosylate Cloth for Hyperhidrosis Therapeutic Cheat Sheet
Hyperhidrosis affects approximately 4.8% of the U.S. population1 and causes patients significant psychosocial distress. Patients are looking to maximize non-invasive treatment options while avoiding systemic side effects. We continue our series, Therapeutic Cheat Sheet, with a closer look at glycopyrronium tosylate cloths.
[caption id="attachment_11862" align="alignleft" width="1934"] Click ima …
Hyperhidrosis affects approximately 4.8% of the U.S. population1 and causes patients significant psychosocial distress. Patients are looking to maximize non-invasive treatment options while avoiding systemic side effects. We continue our series, Therapeutic Cheat Sheet, with a closer look at glycopyrronium tosylate cloths.
[caption id="attachment_11862" align="alignleft" width="1934"] Click ima … Continue reading "Glycopyrronium Tosylate Cloth for Hyperhidrosis Therapeutic Cheat Sheet"
This is the first edition of a quarterly column highlighting articles of interest to dermatologists from non-dermatologic literature. It is already difficult to keep up to date with the high volume and forever expanding literature in dermatologic journals. Additionally, it is virtually impossible to read the full breadth of biomedical literature for materials relevant to the field of dermatology. … 
When standard treatment options fail and corticosteroids are not a long-term option, dermatologists often have to look back to their tool-kit and pull out the “big guns.” Mycophenolate mofetil has emerged as a promising immunosuppressive agent for severe immune-mediated and inflammatory dermatologic disease. We continue our series, Therapeutic Cheat Sheet, with a closer look at mycophenolate m … 
On this Mnemonic Monday, we challenge you to remember major causes of drug-induced Stevens-Johnson Syndrome (SJS) with the following mnemonic:
SANA
Sulfonamides
Anticonvulsants
NSAIDs
Allopurinol
Click HERE to print your mnemonic card.
Study More!
Need a refresher on Stevens-Johnson Syndrome? Check out the following pages of your 2019 Derm In-Review Study Guide:
Stevens-Johnso … 
In this month’s installment of our Therapeutic Cheat Sheet Series, we will review the topical immunomodulatory agent imiquimod. Originally approved for the treatment of external genital warts, FDA approval has expanded to include use as field therapy for actinic keratoses as well as treatment of superficial basal cell carcinomas. Here’s what you need to know about imiquimod.
[caption id=" … 